287 related articles for article (PubMed ID: 17484870)
1. High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants.
Ng PC; Lee CH; Wong SP; Lam HS; Liu FY; So KW; Lee CY; Fok TF
Gastroenterology; 2007 May; 132(5):1726-39. PubMed ID: 17484870
[TBL] [Abstract][Full Text] [Related]
2. Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants.
Ng PC; So KW; Fung KS; Lee CH; Fok TF; Wong E; Wong W; Cheung KL; Cheng AF
Arch Dis Child Fetal Neonatal Ed; 2001 May; 84(3):F177-82. PubMed ID: 11320044
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of intermediate-dose oral erythromycin on very low birth weight infants with feeding intolerance.
Ng YY; Su PH; Chen JY; Quek YW; Hu JM; Lee IC; Lee HS; Chang HP
Pediatr Neonatol; 2012 Feb; 53(1):34-40. PubMed ID: 22348492
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial of early parenteral nutrition cycling to prevent cholestasis in very low birth weight infants.
Salvador A; Janeczko M; Porat R; Sekhon R; Moewes A; Schutzman D
J Pediatr; 2012 Aug; 161(2):229-33.e1. PubMed ID: 22424948
[TBL] [Abstract][Full Text] [Related]
5. Establishing enteral feeding in preterm infants with feeding intolerance: a randomized controlled study of low-dose erythromycin.
Ng SC; Gomez JM; Rajadurai VS; Saw SM; Quak SH
J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):554-8. PubMed ID: 14581796
[TBL] [Abstract][Full Text] [Related]
6. Oral erythromycin for treatment of feeding intolerance in preterm infants: a preliminary report.
Sekteera W; Nuntnarumit P; Supapannachart S
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1177-82. PubMed ID: 12549792
[TBL] [Abstract][Full Text] [Related]
7. Use of oral erythromycin for the treatment of gastrointestinal dysmotility in preterm infants.
Ng PC
Neonatology; 2009; 95(2):97-104. PubMed ID: 19218823
[TBL] [Abstract][Full Text] [Related]
8. Analysis of risk factors for parenteral nutrition-associated cholestasis in preterm infants: a multicenter observational study.
Wang YS; Shen W; Yang Q; Lin R; Tang LX; Bai RM; Yang D; Zhang J; Zhang YJ; Yu WT; Song SR; Kong J; Song SY; Mao J; Tong XM; Li ZK; Wu F; Lin XZ
BMC Pediatr; 2023 May; 23(1):250. PubMed ID: 37210514
[TBL] [Abstract][Full Text] [Related]
9. Erythromycin and feeding intolerance in premature infants: a randomized trial.
Aly H; Abdel-Hady H; Khashaba M; El-Badry N
J Perinatol; 2007 Jan; 27(1):39-43. PubMed ID: 17036029
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of serum amyloid A for prediction of neonatal cholestasis associated with parenteral nutrition in premature infants.
Özkan H; Köksal N; Doğan P; Güney-Varal İ; Bağcı O; Özgür T
Turk J Pediatr; 2019; 61(1):26-33. PubMed ID: 31559718
[TBL] [Abstract][Full Text] [Related]
11. A controlled trial of erythromycin and UDCA in premature infants during parenteral nutrition in minimizing feeding intolerance and liver function abnormalities.
Gokmen T; Oguz SS; Bozdag S; Erdeve O; Uras N; Dilmen U
J Perinatol; 2012 Feb; 32(2):123-8. PubMed ID: 21566568
[TBL] [Abstract][Full Text] [Related]
12. Erythromycin for feeding intolerance in preterm infants.
Ng E; Shah V
Cochrane Database Syst Rev; 2000; (2):CD001815. PubMed ID: 10796273
[TBL] [Abstract][Full Text] [Related]
13. A double-blind randomised controlled trial of fish oil-based versus soy-based lipid preparations in the treatment of infants with parenteral nutrition-associated cholestasis.
Lam HS; Tam YH; Poon TC; Cheung HM; Yu X; Chan BP; Lee KH; Lee BS; Ng PC
Neonatology; 2014; 105(4):290-6. PubMed ID: 24576844
[TBL] [Abstract][Full Text] [Related]
14. A pioneering study: oral clarithromycin treatment for feeding intolerance in very low birth weight preterm infants.
Sancak S; Gursoy T; Tuten A; Arman D; Karatekin G; Ovali F
J Matern Fetal Neonatal Med; 2018 Apr; 31(8):988-992. PubMed ID: 28279123
[TBL] [Abstract][Full Text] [Related]
15. Erythromycin for feeding intolerance in preterm infants.
Ng E; Shah V
Cochrane Database Syst Rev; 2001; (2):CD001815. PubMed ID: 11406010
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of oral erythromycin for treatment of feeding intolerance in preterm infants.
Nuntnarumit P; Kiatchoosakun P; Tantiprapa W; Boonkasidecha S
J Pediatr; 2006 May; 148(5):600-5. PubMed ID: 16737869
[TBL] [Abstract][Full Text] [Related]
17. Erythromycin treatment for gastrointestinal dysmotility in preterm infants.
Ng PC; Fok TF; Lee CH; Wong W; Cheung KL
J Paediatr Child Health; 1997 Apr; 33(2):148-50. PubMed ID: 9145359
[TBL] [Abstract][Full Text] [Related]
18. Use of cholecystokinin-octapeptide for the prevention of parenteral nutrition-associated cholestasis.
Teitelbaum DH; Tracy TF; Aouthmany MM; Llanos A; Brown MB; Yu S; Brown MR; Shulman RJ; Hirschl RB; Derusso PA; Cox J; Dahlgren J; Groner JI; Strouse PJ
Pediatrics; 2005 May; 115(5):1332-40. PubMed ID: 15867044
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants.
Mansi Y; Abdelaziz N; Ezzeldin Z; Ibrahim R
Neonatology; 2011; 100(3):290-4. PubMed ID: 21701222
[TBL] [Abstract][Full Text] [Related]
20. A multicenter, randomized, double-blind, placebo-controlled trial of the prokinetic agent erythromycin in the postoperative recovery of infants with gastroschisis.
Curry JI; Lander AD; Stringer MD;
J Pediatr Surg; 2004 Apr; 39(4):565-9. PubMed ID: 15065029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
